HMG499

CAS No. 2416941-68-7

HMG499 ( —— )

Catalog No. M21875 CAS No. 2416941-68-7

HMG499 is a potent and selective HMG-CoA reductase inhibitor with an IC50 of 0.41 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1229 Get Quote
50MG 2507 Get Quote
100MG 3168 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    HMG499
  • Note
    Research use only, not for human use.
  • Brief Description
    HMG499 is a potent and selective HMG-CoA reductase inhibitor with an IC50 of 0.41 μM.
  • Description
    HMG499 is a potent and selective HMG-CoA reductase inhibitor with an IC50 of 0.41 μM. HMG499 can prevent statins-induced accumulation of HMGCR, reduce serum cholesterol levels and decrease atherosclerosis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    HMGCR
  • Recptor
    IC50: 0.41 μM (HMG-CoA reductase)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2416941-68-7
  • Formula Weight
    498.78
  • Molecular Formula
    C??H??O?
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C[C@H](CCCC(CC=C)(CC=C)O)[C@H]1CC[C@@]2([H])[C@]3([H])[C@@H](O)C=C4C(C)(C)[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Jiang SY, et al. Discovery of a potent HMG-CoA reductase degrader that eliminates statin-induced reductase accumulation and lowers cholesterol. Nat Commun. 2018 Dec 3;9(1):5138.
molnova catalog
related products
  • Atorvastatin

    A competitive inhibitor of HMG-CoA reductase that acts as a lipid-lowering agent for prevention of events associated with cardiovascular disease.

  • Apomine

    Apomine, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and has been implicated in the regulation of myeloma in vivo. Apomine accelerates the degradation of 3-hydroxy-3-methylglutaryl-CoA reductase and stimulates low-density lipoprotein receptor activity.

  • Simvastatin

    A potent, competitive inhibitor of HMG-CoA reductase (HMGCR) with Kd of 0.1-0.2 nM.